X4 Pharmaceuticals, Inc. buy B. Riley
Start price
31.08.23
/
50%
€1.19
Target price
31.08.24
-
Performance (%)
-48.19%
End price
01.09.24
€0.62
Summary
This prediction ended on 01.09.24 with a price of €0.62. The BUY prediction by B__Riley for X4 Pharmaceuticals, Inc. performed very badly with a performance of -48.19%. B__Riley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| X4 Pharmaceuticals, Inc. | - | - | - |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% |
Comments by B__Riley for this prediction
In the thread X4 Pharmaceuticals, Inc. diskutieren
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its "buy" rating re-affirmed by analysts at B. Riley.
Ratings data for XFOR provided by MarketBeat
In the thread Trading X4 Pharmaceuticals, Inc.
Die von B__Riley gewählte maximale Laufzeit wurde überschritten